Nowadays, cancer cell immunotherapy is adopting a variety of cellular immunotherapy methods, or combined with three standard therapies, which include: “surgery" for direct resection of tumor tissue;” radiotherapy" for killing tumor tissue with X rays or proton / heavy ions and "chemotherapy or targeted therapy" using cytotoxic anticancer agents or molecular targeted drugs. In recent years, with the advancement of medical technology, immunotherapy, which uses the immune function of the body to kill cancer cells, has become the fourth method of cancer treatment.
Cellular immunotherapy for cancer includes active immunotherapy that initiates autoimmune function in vivo, such as vaccines, immune checkpoint inhibitor therapy to relieve the immune brake (inhibits), adoptive immunotherapy for in vitro proliferation T cell transfusion, In vitro processing of proliferative dendritic cells in vivo to produce antigen-antibody and so on. Among them, dendritic cells and NK cells combined therapy has become one of the most effective techniques for cancer treatment. It eventually controls the disease via kill cancer cells.